Eltrombopag to Treat Thrombocytopenia During Last Month of Pregnancy in a Woman With MYH9-Related Disease: A Case Report

A A Pract. 2018 Jan 1;10(1):10-12. doi: 10.1213/XAA.0000000000000621.

Abstract

MYH9-related disease (MYH9-RD) is an inherited rare autosomal dominant macrothrombocytopenia. Patients with MYH9-RD have giant platelets and leukocyte inclusion bodies caused by mutations in the MYH9 gene encoding the non-muscle myosin heavy chain II-A. Before identification of the causative gene, patients were diagnosed as Epstein or Fechtner or Sebastian syndromes or May-Hegglin anomaly. As with other inherited thrombocytopenias, the risk of increased bleeding during perioperative period or delivery is a major concern. We report here the first successful cesarean delivery of a woman with MYH9-RD treated with eltrombopag during the last month of pregnancy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Benzoates / therapeutic use*
  • Female
  • Hearing Loss, Sensorineural / drug therapy*
  • Humans
  • Hydrazines / therapeutic use*
  • Pregnancy
  • Pregnancy Complications, Hematologic / drug therapy*
  • Pyrazoles / therapeutic use*
  • Receptors, Thrombopoietin / agonists*
  • Thrombocytopenia / congenital*
  • Thrombocytopenia / drug therapy*

Substances

  • Benzoates
  • Hydrazines
  • Pyrazoles
  • Receptors, Thrombopoietin
  • eltrombopag

Supplementary concepts

  • MYH9-Related Disorders